Cargando…
Effect of Different Adjuvants on Immune Responses Elicited by Protein-Based Subunit Vaccines against SARS-CoV-2 and Its Delta Variant
The global pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become more serious because of the continuous emergence of variants of concern (VOC), thus calling for the development of broad-spectrum vaccines with greater efficac...
Autores principales: | Zhang, Naru, Ji, Qianting, Liu, Zezhong, Tang, Kaiming, Xie, Yubin, Li, Kangchen, Zhou, Jie, Li, Sisi, Shang, Haotian, Shi, Zecan, Zheng, Tianyu, Yao, Jiawei, Lu, Lu, Yuan, Shuofeng, Jiang, Shibo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950793/ https://www.ncbi.nlm.nih.gov/pubmed/35336907 http://dx.doi.org/10.3390/v14030501 |
Ejemplares similares
-
A Perspective on the Roles of Adjuvants in Developing Highly Potent COVID-19 Vaccines
por: Zhang, Naru, et al.
Publicado: (2022) -
Corrigendum: Advancement in the development of therapeutics against Zika virus infection
por: Li, Kangchen, et al.
Publicado: (2022) -
Advancement in the Development of Therapeutics Against Zika Virus Infection
por: Li, Kangchen, et al.
Publicado: (2022) -
Receptor-binding domain-based subunit vaccines against MERS-CoV
por: Zhang, Naru, et al.
Publicado: (2015) -
Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus
por: Zhang, Naru, et al.
Publicado: (2016)